Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, Fujian, 361000, China.
School of Clinical Medicine, Fujian Medical University, Fujian, 350000, China.
Trials. 2024 Jul 15;25(1):480. doi: 10.1186/s13063-024-08311-6.
Postoperative sleep disturbance has a potentially detrimental effect on postoperative recovery. Perioperative patients are affected by several factors. General anesthesia induces a non-physiological state that does not resemble natural sleep. Exposure to propofol/sevoflurane can lead to desynchronization of the circadian rhythm, which may result in postoperative sleep disturbance characterized by mid-cycle advancement of sleep and daytime sleepiness. Dexmedetomidine is a highly selective α2-adrenoceptor agonist with a unique sedative effect that facilitates the transition from sleep to wakefulness. Basic research has shown that dexmedetomidine induces deep sedation, similar to physical sleep, and helps maintain forebrain connectivity, which is likely to reduce delirium after surgery. The aim of this study is to evaluate the influence of exposure to the mono-anesthetic propofol on the development of postoperative sleep disturbance in young and middle-aged female patients undergoing hysteroscopy and whether prophylactic administration of dexmedetomidine influences reducing postoperative sleep disturbance.
This prospective randomized controlled trial (RCT) will include 150 patients undergoing hysteroscopy at the First Affiliated Hospital of Xiamen University. Participants will be randomly assigned to three groups in a 1:1:1 ratio. The dexmedetomidine group will have two subgroups and will receive a nasal spray of 0.2 µg/kg or 0.5 µg/kg 25 min before surgery, while the control group will receive a saline nasal spray. Three groups will undergo hysteroscopy with propofol-based TIVA according to the same scheme. Sleep quality will be measured using a wearable device and double-blind sleep assessments will be performed before surgery and 1, 3, and 7 days after surgery. SPSS 2.0 is used for statistical analysis. A χ test is used to compare groups, and t-test is used to determine statistical the significance of continuous variables.
The purpose of this study is to investigate the incidence of propofol-associated sleep disorders and to test a combination of dexmedetomidine anesthesia regimen for the prevention of postoperative sleep disorders. This study will help to improve patients' postoperative satisfaction and provide a new strategy for comfortable perioperative medical treatment.
ClinicalTrials.gov NCT06281561. Registered on February 24, 2024.
术后睡眠障碍可能对术后恢复产生潜在的不利影响。围手术期患者受到多种因素的影响。全身麻醉会诱导出一种非生理状态,与自然睡眠并不相似。暴露于丙泊酚/七氟醚会导致昼夜节律失同步,这可能导致术后睡眠障碍,表现为睡眠中期提前和白天嗜睡。右美托咪定是一种高选择性的α2-肾上腺素受体激动剂,具有独特的镇静作用,可促进从睡眠到清醒的过渡。基础研究表明,右美托咪定诱导深度镇静,类似于生理性睡眠,并有助于维持大脑前区的连接性,这可能会减少术后谵妄的发生。本研究旨在评估单麻醉药丙泊酚暴露对年轻和中年女性行宫腔镜检查患者术后睡眠障碍发展的影响,以及预防性给予右美托咪定是否会影响减少术后睡眠障碍。
这是一项前瞻性随机对照试验(RCT),将纳入 150 名在厦门大学附属第一医院行宫腔镜检查的患者。参与者将按照 1:1:1 的比例随机分为三组。右美托咪定组将分为两个亚组,在手术前 25 分钟分别给予 0.2μg/kg 或 0.5μg/kg 的鼻腔喷雾,而对照组将给予生理盐水鼻腔喷雾。三组患者将根据相同的方案接受丙泊酚为基础的全凭静脉麻醉(TIVA)行宫腔镜检查。使用可穿戴设备测量睡眠质量,并在术前和术后 1、3 和 7 天进行双盲睡眠评估。使用 SPSS 2.0 进行统计分析。采用卡方检验比较组间差异,采用 t 检验确定连续变量的统计学显著性。
本研究旨在调查丙泊酚相关睡眠障碍的发生率,并测试右美托咪定麻醉方案联合预防术后睡眠障碍。本研究将有助于提高患者的术后满意度,并为舒适的围手术期治疗提供新策略。
ClinicalTrials.gov NCT06281561。于 2024 年 2 月 24 日注册。